Inventor · disambiguated record
Michael Kragh
Also filed as: KRAGH MICHAEL
13 granted patents·6 pending applications·59 citations·filing 2001–2024
90Inventor score
Files withSYMPHOGEN AS12CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2SERVIER LAB2PEDERSEN MIKKEL W1PEDERSEN MIKKEL WANDAHL1
Top patents by PatentIndex Score
19 records- 0193US11034765B2Anti-PD-1 antibodies and compositionsSYMPHOGEN AS·Filed 2016·Granted Jun 15, 2021·17 cites·20 claims
- 0291US10058610B2Methods for treating cancer by administering humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2016·Granted Aug 28, 2018·9 cites·20 claims
- 0386US11390676B2Anti-LAG-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·3 cites·15 claims
- 0485US11390674B2Anti-TIM-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·4 cites·23 claims
- 0579US9155802B2Pan-HER antibody compositionPEDERSEN MIKKEL W·Filed 2011·Granted Oct 13, 2015·4 cites·18 claims
- 0677US9527913B2Humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2013·Granted Dec 27, 2016·4 cites·8 claims
- 0776US10221246B2Pan-HER antibody compositionSYMPHOGEN AS·Filed 2016·Granted Mar 5, 2019·2 cites·8 claims
- 0876US8663640B2Methods using recombinant anti-epidermal growth factor receptor antibody compositionsPEDERSEN MIKKEL WANDAHL·Filed 2009·Granted Mar 4, 2014·4 cites·59 claims
- 0975US2024052032A1Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 1073US11834503B2Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Granted Dec 5, 2023·0 cites·20 claims
- 1173US2024270848A1Combination therapies targeting pd-1, tim-3, and lag-3SERVIER LAB·Filed 2024·Application pending·0 cites
- 1271US11939380B2Combination therapies targeting PD-1, TIM-3, and LAG-3SYMPHOGEN AS·Filed 2018·Granted Mar 26, 2024·1 cites·16 claims
- 1367US2022380470A1Combination therapies targeting pd-1, tim-3, and lag-3SYMPHOGEN AS·Filed 2022·Application pending·0 cites
- 1466US6701171B2Method and apparatus for non-invasive detection of angiogenic and anti-angiogenic activity in living tissueUNIV KOEBENHAVN·Filed 2001·Granted Mar 2, 2004·11 cites·9 claims
- 1557US2018344846A1Humanized pan-her antibody compositionsSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 1655US12030942B2Anti-PD-1 antibodies and compositionsSERVIER LAB·Filed 2021·Granted Jul 9, 2024·0 cites·18 claims
- 1750US2016089435A1Pan-her antibody compositionSYMPHOGEN AS·Filed 2015·Application pending·0 cites
- 1841US2020347140A1Compositions and methods for treating cancer with anti-egfr antibodiesSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 1931US10450376B2Anti-MET antibodies and compositionsSYMPHOGEN AS·Filed 2015·Granted Oct 22, 2019·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Michael Kragh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →